|
It is reported in the literature titled: ¿comparison of cold snare polypectomy and endoscopic mucosal resection for 3¿10-mm colorectal polyps in end-stage renal disease patients,¿ patients experienced adverse events after cold snare polypectomy procedures using olympus devices.Case with patient identifier (b)(6) reports the sd-210u-10 used in the procedures.Case with patient identifier (b)(6) reports the ch-q260ai used in the procedures.Study aim: compare the efficacy and safety of csp and endoscopic mucosal resection (emr) in esrd patients.Method: this study was a retrospective study.We performed propensity score-matched analysis in patients with esrd who underwent endoscopic resection for 3¿10-mm-sized colorectal polyps at seoul st.Mary¿s hospital, from january 2014 to december 2019.Results: after 1:1 ratio matching, 406 polyps were included: 203 polyps were resected with csp and 203 polyps with emr.There was no difference between the csp group and emr group in incomplete resection rate (4.43% vs.1.97%, p = 0.16).There were no differences between the csp and emr group for immediate bleeding (5.42% vs.7.88%, p = 0.32) and delayed bleeding (0% vs.0.49%, p = 1.00).No perforation occurred in either group.Conclusion: there were no differences between the csp and emr group in terms of efficacy and safety.Csp can be one of the standard methods for the removal of 3¿10-mm-sized colorectal polyps in patients with esrd.Esrd patients are at an increased risk of bleeding because of the following conditions: uremic platelet dysfunction, abnormal platelet endothelium interaction, use of antiplatelet medication, use of anticoagulants, accumulation of medications in the blood leading to poor clearance, heparin use during dialysis, and hemodialysis itself.In this study, we found more frequent immediate bleeding in esrd patients than in the general population.We believe that the high risk of bleeding in esrd patients and the use of antithrombotic agents affected these outcomes.Nevertheless, there was no significant difference in immediate bleeding between csp and emr groups (5.42% vs.7.88%; p = 0.32).In addition, immediate bleeding could be adequately controlled by endoscopic hemostatic procedures (therapeutic clipping and electrocautery), and there were no cases that required additional therapeutic treatments such as blood transfusions, hospital admission, or embolization.There is no report of olympus device malfunction described in this study.
|
|
This report is being supplemented to provide a correction and additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Olympus will continue to monitor field performance for this device.
|